journal of men's health
Volume 7, Issue 1 , Pages 64-72 , March 2010

Primary transitional cell carcinoma of the prostate: a male disease with dismal prognosis despite cisplatin-based systemic chemotherapy

  • Javier C. Angulo, MD, PhD

      Affiliations

    • Department of Urology, Hospital Universitario de Getafe, Carretera de Toledo Km 12.500, Getafe 28905, Madrid, Spain
    • Corresponding Author InformationCorresponding author.
    • ,
  • Carlos Núñez, MD

      Affiliations

    • Department of Urology, Hospital Universitario de Getafe, Madrid, Spain
    • ,
  • Javier Gonzalez, MD

      Affiliations

    • Department of Urology, Hospital Universitario de Getafe, Madrid, Spain
    • ,
  • Emilio Hernández, MD

      Affiliations

    • Department of Urology, Hospital Universitario de Getafe, Madrid, Spain
    • ,
  • Ernesto Castillo, MD

      Affiliations

    • Department of Radiology, Hospital Universitario de Getafe, Madrid, Spain
    • ,
  • José M. Rodríguez-Barbero, MD

      Affiliations

    • Departments of Pathology, Hospital Universitario de Getafe, Servicio Madrileño de Salud, Universidad Europea de Madrid, Madrid, Spain

Received 28 September 2009 ,Accepted 9 December 2009.

References 

  1. Sawczuk I, Tannenbaum M, Olsson CA, deVere White R. Primary transitional cell carcinoma of prostatic periurethral ducts. Urology. 1985;25:339–343
  2. Ende N, Woods LP, Shelley HS. Carcinoma originating in ducts surrounding the prostatic urethra. Am J Clin Pathol. 1963;40:183–189
  3. Donat SM, Genega EM, Herr HW, Reuter VE. Mechanisms of prostatic stromal invasión in patients with bladder cancer: clinical significance. J Urol. 2001;165:1117–1120
  4. Nicolaisen GS, Williams RD. Primary transitional cell carcinoma of prostate. Urology. 1984;24:544–549
  5. Algaba F, Santaularia JM, Lamas M, Ayala G. Transitional cell carcinoma of the prostate. Eur Urol. 1985;11:87–90
  6. Busto Castañón L, Sousa Escandon A, Rodriguez Garcia J, Guitian Barreiro D, Gomez Veiga F, Gonzalez Martin M. Carcinoma de células transicionales de la próstata. A propósito de dos observaciones. Actas Urol Esp. 1990;14:365–367
  7. Queipo Zaragozá JA, Budía Alba A, Pérez Ebrí M, Vera Donoso CD, Vera Sempere F, Jimenez Cruz JF. Carcinoma transicional primario de ductos prostáticos. Actas Urol Esp. 2000;24:406–412
  8. Mallén Mateo E, Gil Martínez P, Sancho Serrano C, García de Jalón Martínez A, Pascual Regueiro D, Gil Sanz MJ, et al. Carcinoma transicional primario puro de próstata. Revisión de nuestra serie. Actas Urol Esp. 2004;28:377–380
  9. Wernert N, Goebbels R, Bonkhoff H, Dhom G. Squamous cell carcinoma of the prostate. Histopathology. 1990;17:339–344
  10. Sarma DP, Weilbaecher TG, Moon TD. Squamous cell carcinoma of prostate. Urology. 1991;37:260–262
  11. Majeed F, Javed TA, Khan AU, Koerber RK. Primary squamous cell carcinoma of the prostate: a novel chemotherapy regimen. J Urol. 2002;168:640
  12. Mai KT, Collins JP, Veinot JP. Prostatic adenocarcinoma with urothelial (transitional cell) carcinoma features. Appl Immunohistochem Mol Morphol. 2002;10:231–236
  13. Greene LF, O’Dea MJ, Dockerty MB. Primary transitional cell carcinoma of the prostate. J Urol. 1976;116:761–763
  14. Kirk D, Hinton CE, Shaldon C. Transitional cell carcinoma of the prostate. Br J Urol. 1979;51:575–578
  15. Alexander SJ, Lee SS, Bekhrad A. Transitional cell carcinoma of the prostate: response to treatment with cisplatinum and cyclophosphamide. J Urol. 1984;131:975–977
  16. Tan MO, Tuncel A, Deniz N, Uzcum N, Dursun A, Bozkirli I. Case report: Incidental primary transitional cell carcinoma of the prostate treated with transurethral prostatectomy only. Tumori. 2003;89:440–442
  17. Wolfe JH, Lloyd-Davies RW. The management of transitional cell carcinoma in the prostate. Br J Urol. 1981;53:253–257
  18. Wadhwa P, Mandal AK, Singh SK, Goswami AK, Sharma SC, Joshi K, et al. Primary transitional cell carcinoma of the prostate presenting as a rectal ulcer. Urol Int. 2004;72:176–177
  19. Scher HI, Yagoda A, Herr HW, Sternberg CN, Morse MJ, Sogani PC, et al. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors. J Urol. 1988;139:475–477
  20. Takashi M, Sakata T, Nagai T, Kato T, Sahashi M, Koshikawa T, et al. Primary transitional cell carcinoma of prostate: case with lymph node metastasis eradicated by neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) therapy. Urology. 1990;36:96–98
  21. Dexeus FH, Logothetis CJ, Samuels ML, Ayala AG, Hossan E. Complete responses in metastatic transitional cell carcinoma of the prostate with cisplatin regimens. J Urol. 1987;137:122–125
  22. Stewart DJ, Dahrouge S. Mitoxantrone in the treatment of metastatic transitional cell carcinoma of the prostate. A case report. Am J Clin Oncol. 1997;20:381–382
  23. In:  Greene FL,  Compton CC,  Fritz AG,  Shah JP,  Winchester DP editor. AJCC Cancer Staging Atlas. New York: Springer; 2006;p. 342–346
  24. Palou J, Daniel J, Klotz L, Word D, Cookson M, Lerner S, et al. Urothelial carcinoma of the prostate. Urology. 2007;69:50–61

PII: S1875-6867(09)00373-X

doi: 10.1016/j.jomh.2009.12.004

journal of men's health
Volume 7, Issue 1 , Pages 64-72 , March 2010

Article Tools

* Image Usage & Resolution